| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8442586 | European Journal of Cancer | 2015 | 8 Pages |
Abstract
Prognosis in MCS varies considerably. Metastatic disease at diagnosis has the strongest impact on survival. Complete resection and adjuvant chemotherapy should be considered as standard of care for localised disease.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Anna Maria Frezza, Marilena Cesari, Daniel Baumhoer, David Biau, Stephen Bielack, Domenico Andrea Campanacci, José Casanova, Claire Esler, Stefano Ferrari, Philipp T. Funovics, Craig Gerrand, Robert Grimer, Alessandro Gronchi, Nicolas Haffner,